2种治疗方案治疗中风后遗症的成本-效果分析  

Cost-effectiveness Analysis of 2 Therapeutic Schemes for Apoplexy Sequela

作　　者：胡孔友[1] 陈际连[2] 蔡越冬[1] 

机构地区：[1]广州白云山和记黄埔中药有限公司,广州510515 [2]安徽中医学院第一附属医院,合肥230031

出　　处：《中国药房》2012年第44期4187-4188,共2页China Pharmacy

摘　　要：目的:评价复方丹参片与胞磷胆碱钠注射液治疗中风后遗症的经济学效果。方法:将104例中风后遗症患者,随机分为A组(复方丹参片,54例)和B组(胞磷胆碱钠注射液,50例),观察2组的临床效果,并运用药物经济学比较其成本-效果。结果:A组治疗成本为48元,有效率为83%;B组治疗成本为1632元,有效率为80%,2组成本-效果比分别为0.58和20.4。以A组为参照的增量成本-效果比为-528。结论:与胞磷胆碱钠注射液比较,复方丹参片治疗中风后遗症疗效相当,但经济性较好。OBJECTIVE：To analyze and evaluate the cost-effectiveness of Compound danshen tablets and Citicoline sodium injection in the treatment of apoplexy sequela.METHODS：104 cases of apoplexy sequela were randomly divided into group A（Compound danshen tablets,54 cases） and group B（Citicoline sodium injection,50 cases）.Cost-effectiveness analysis was conducted with the pharmacoeconomic method.RESULTS：The cost was 48 yuan in Compound danshen tablets group and 1 632 yuan in Citicoline sodium injection group.The effective rates were 83% and 80%,and the C/E were 0.58 and 20.4,respectively.Referred to group A,the incremental cost effectiveness ratios were-528.CONCLUSION：Compound danshen tablets have well curative effect and low cost in the treatment of apoplexy sequela.

关 键 词：复方丹参片 胞磷胆碱钠注射液 成本-效果分析 

分 类 号：R956[医药卫生—药学]